ESMO 2023

European Society for Medical Oncology (ESMO), 2023
Oct 20-24, 2023
Madrid, Spain

Material Type

Poster
Matching-Adjusted Indirect Comparison (MAIC) of Axicabtagene Ciloleucel (axi-cel) and Epcoritamab (epcor) in Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) After at Least Two Prior Systemic Therapies (3L+)
Author: Oluwole, O
Yescarta
Poster
Matching-Adjusted Indirect Comparison (MAIC) of Axicabtagene Ciloleucel (axi-cel) and Glofitamab (glofit) in Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) After at Least Two Prior Systemic Therapies (3L+)
Author: Locke, F
Yescarta

Call

Kite Medical Information

For product inquiries, adverse events, and products complaints, please call 1-844-454-KITE (1-844-454-5483), Monday-Friday, 5:00am-6:00pm US PST.

Offcanvas title

[contact-form-7 id="508a1ec" title="Submit Medical Inquiry"]